Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Cancer Research|November 17, 2006
Biological properties of IDN5174, a new synthetic camptothecin with the open lactone ringGiovanni L Beretta, Giovanna Petrangolini, Michelandrea De Cesare, et al.
Cancer|August 5, 2020
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma GroupFederica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, et al.
Pharmaceutics|December 11, 2019
Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic DrugsLucia Morelli, Sara Gimondi, Marta Sevieri, et al.
Heliyon|August 22, 2024
Differential effect of asparagine and glutamine removal on three adenocarcinoma cell linesGreta Pessino, Leonardo Lonati, Claudia Scotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2010
Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitineClaudio Pisano, Loredana Vesci, Ferdinando Maria Milazzo, et al.
Neurobiology of Disease|December 13, 2016
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsyValentina Iori, Anand M Iyer, Teresa Ravizza, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2024
A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic miceMaria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, et al.
Plos One|October 12, 2017
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insightsPaola Marmiroli, Beatrice Riva, Eleonora Pozzi, et al.
The Oncologist|March 29, 2014
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targetsFrancesca Toffalorio, Gianluca Spitaleri, Chiara Catania, et al.
Haematologica|December 10, 2020
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemiaAlaeddin Khalil, Gudrun Würthwein, Jana Golitsch, et al.
Pageof 10